"Nucleofection Enters the High Throughput Arena"
/pressemitteilung/pdf/68965/meldung.pdf
/pressemitteilung/pdf/68965/meldung.pdf
Applied Materials, Inc. announced today that it has completed the acquisition of Applied Films Corporation, a leading su…
As already announced beginning of June, Applied Films has received a major contract for its micromorph thin film solar c…
DeveloGen, a biopharmaceutical company active in the discovery and development of novel therapeutic drugs for the treatm…
Before the start of the prestigious 2006 Symposium on VLSI Technology, Texas Instruments Incorporated (NYSE: TXN) (TI) u…
MOLOGEN AG announces that they obtained medicine status for their cell-based gene therapy against kidney cancer. This st…
Applied Films today announced the receipt of a major contract for its micromorph thin film solar cell production equipme…
Linear Technology Corporation introduces the LTC4085, a monolithic autonomous power manager, ideal diode controller and…
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) (“Oncolytics”) has been granted U.S. Patent 7,052,832 entitled “Methods…
Gene Bridges announced today that it is supplying the High Q Foundation with optimized targeting vectors to generate mou…